Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
Molecular Weight | 553.4 g/mol |
---|---|
Molecular Formula | C23H30Cl2N8O4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 8 |
Exact Mass | 552.1767069 g/mol |
Monoisotopic Mass | 552.1767069 g/mol |
Topological Polar Surface Area | 140 A^2 |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 796 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Copanlisib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Copanlisib, including repackagers and relabelers. The FDA regulates Copanlisib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Copanlisib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Copanlisib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Copanlisib supplier is an individual or a company that provides Copanlisib active pharmaceutical ingredient (API) or Copanlisib finished formulations upon request. The Copanlisib suppliers may include Copanlisib API manufacturers, exporters, distributors and traders.
click here to find a list of Copanlisib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Copanlisib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Copanlisib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Copanlisib GMP manufacturer or Copanlisib GMP API supplier for your needs.
A Copanlisib CoA (Certificate of Analysis) is a formal document that attests to Copanlisib's compliance with Copanlisib specifications and serves as a tool for batch-level quality control.
Copanlisib CoA mostly includes findings from lab analyses of a specific batch. For each Copanlisib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Copanlisib may be tested according to a variety of international standards, such as European Pharmacopoeia (Copanlisib EP), Copanlisib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Copanlisib USP).
LOOKING FOR A SUPPLIER?